USA - engelska - NLM (National Library of Medicine)

fresenius kabi usa, llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate oral solution is indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

lloyds pharmacy ltd - paracetamol; caffeine; phenylephrine hydrochloride - oral capsule - 300mg ; 25mg ; 5mg

Malta - engelska - Medicines Authority

alliance pharmaceuticals limited - paracetamol; phenylephrine hydrochloride; caffeine; diphenhydramine hydrochloride; codeine phosphate - film-coated tablet - paracetamol 500 mg; phenylephrine hydrochloride 10 mg; caffeine 30 mg; diphenhydramine hydrochloride 15 mg; codeine phosphate 10 mg - cough and cold preparations

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - caffeine; phenylephrine hydrochloride; paracetamol - oral capsule - 25mg ; 6.1mg ; 500mg

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

the boots company plc - caffeine; phenylephrine hydrochloride; paracetamol - oral capsule - 25mg ; 6.1mg ; 500mg

Irland - engelska - HPRA (Health Products Regulatory Authority)

phoenix labs - caffeine; diphenhydramine hydrochloride; paracetamol; phenylephrine hydrochloride; ascorbic acid - film-coated tablet + tablet - 30 mg/15 mg/500 mg/10 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

the boots company plc - paracetamol; caffeine; phenylephrine hydrochloride - oral capsule - 300mg ; 25mg ; 5mg

USA - engelska - NLM (National Library of Medicine)

auromedics pharma llc - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection, usp is indicated for the treatment of apnea of prematurity. caffeine citrate injection is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

USA - engelska - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate injection is indicated for the treatment of apnea of prematurity. caffeine citrate injection is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

USA - engelska - NLM (National Library of Medicine)

sagent pharmaceuticals - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate 20 mg in 1 ml - caffeine citrate is indicated for the treatment of apnea of prematurity. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components.